Armata Pharmaceuticals, Inc.
ARMP
$5.64
-$0.35-5.81%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.16M | 2.17M | 491.00K | 1.24M | 2.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.16M | 2.17M | 491.00K | 1.24M | 2.97M |
| Cost of Revenue | 5.82M | 167.00K | 5.43M | 8.45M | 9.49M |
| Gross Profit | -4.67M | 2.00M | -4.94M | -7.22M | -6.51M |
| SG&A Expenses | 3.11M | 2.62M | 3.25M | 3.32M | 3.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.94M | 9.01M | 8.68M | 11.77M | 12.73M |
| Operating Income | -7.78M | -6.84M | -8.19M | -10.54M | -9.76M |
| Income Before Tax | -26.68M | -16.30M | -6.53M | 2.60M | -5.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.68M | -16.30M | -6.53M | 2.60M | -5.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.68M | -16.30M | -6.53M | 2.60M | -5.48M |
| EBIT | -7.78M | -6.84M | -8.19M | -10.54M | -9.76M |
| EBITDA | -7.41M | -6.48M | -7.81M | -10.16M | -9.44M |
| EPS Basic | -0.74 | -0.45 | -0.18 | 0.07 | -0.15 |
| Normalized Basic EPS | -0.21 | -0.18 | -0.20 | -0.24 | -0.21 |
| EPS Diluted | -0.74 | -0.45 | -0.20 | -0.52 | -0.15 |
| Normalized Diluted EPS | -0.21 | -0.18 | -0.12 | -0.14 | -0.21 |
| Average Basic Shares Outstanding | 36.23M | 36.19M | 36.18M | 36.18M | 36.18M |
| Average Diluted Shares Outstanding | 36.23M | 36.19M | 59.48M | 59.08M | 36.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |